CVS Health Corporation

Visual Financials
Company Name: CVS Health Corp
Ticker Symbol: CVS
CIK Number: 0000064803
WWW Address: http://www.cvshealth.com
CEO: Mr. Larry J. Merlo
No. of Employees: 202,000
Common Issue Type: CS
Business Description:CVS Caremark is an integrated pharmacy health care provider. CVS Caremark conducts its business through pharmacy benefit management (PBM), mail order and specialty pharmacy division, CVS Caremark Pharmacy Services, CVS retail stores, and CVS.com.

 
Industry Information: RETAIL - Drug Stores [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 57.38 Down -0.06 - - 57.37 54.61 53.02 5062605
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 74,541.9 1,299.1 0.00 -0.57 2.00 0.0 3.8 82.15 - 51.72
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close54.11$
PE Ratio - LTM0.0
Market Capitalisation74,541.9mil
Latest Shares Outstanding1,299.1mil
Earnings pS (EPS)-0.57$
Dividend pS (DPS)2.00¢
Dividend Yield3.8%
Dividend Payout Ratio%
Revenue per Employee659,590$
Effective Tax Rate1.4%
Float1,295.9mil
Float as % of Shares Outstanding1.0%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.00%
Research & Devlopment (R&D) as % of Revenue0.00%
Gross Profit Margin16.2%
EBITDA Margin3.5%
Pre-Tax Profit Margin0.0%
Assets Turnover133.5%
Return on Assets (ROA)-0.4%
Return on Equity (ROE)-1.2%
Return on Capital Invested (ROCI)-1.7%
Current Ratio1.0
Leverage Ratio (Assets/Equity)3.4
Interest Cover1.5
Total Debt/Equity (Gearing Ratio)1.26
LT Debt/Total Capital55.0%
Working Capital pS0.95$
Cash pS0.00$
Book-Value pS45.94$
Tangible Book-Value pS-43.86$
Cash Flow pS7.59$
Free Cash Flow pS5.55$
KEY FIGURES (LTM): Price info
Price/Book Ratio1.16
Price/Tangible Book Ratio0.00
Price/Cash Flow7.0
Price/Free Cash Flow9.6
P/E as % of Industry Group80.0%
P/E as % of Sector Segment93.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of PaymentCash Payment
Dividend Rate2.00
Current Dividend Yield3.8
5-Y Average Dividend Yield1.1
Payout Ratio0.0
5-Y Average Payout Ratio16.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---3.39,584,40543,849,449
4 Weeks55.7551.7255.16-1.99,610,959182,608,224
13 Weeks58.4051.7252.503.112,308,980787,774,749
26 Weeks76.5751.7274.07-26.911,715,2261,452,688,068
52 Weeks82.1551.7266.03-18.19,519,5272,379,881,812
YTD70.9551.72--17.512,173,4181,314,729,173
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
53.5453.1753.7762.0466.030.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.090.30.08
Income0.0
Dividend0.170.40.13
Capital Spending0.09NA0.02
R&D0.00NA0.00
Normalized Inc.6.93NA5.97
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-0.1-0.115.0
Earnings %23.423.412.1
EPS %30.530.517.5
EPS $0.180.180.45
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio0.63
Current Ratio1.0
Quick Ratio (Acid Test)0.6
Liquidity Ratio (Cash)0.24
Receivables Turnover19.4
Average Collection Period19
Working Capital/Equity2.1
Working Capital pS0.95
Cash-Flow pS8.49
Free Cash-Flow pS6.54
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio1.09
Financial Leverage Ratio (Assets/Equity)1.3
Debt Ratio37.4
Total Debt/Equity (Gearing Ratio)1.26
LT Debt/Equity1.23
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities97.3
Interest Cover1.5
Interest/Capital Invested4.50
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.35
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA8.65
Enterprise Value (EV)/Free Cash Flow37.04
Dividend Yield3.8
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM1.16
Price/Cash Flow Ratio7.0
Price/Free Cash Flow Ratio - LTM9.6
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM18.3
P/E Ratio (26 weeks ago) - LTM16.8
P/E Ratio (52 weeks ago) - LTM17.3
5-Y High P/E Ratio0.0
5-Y Low P/E Ratio0.0
5-Y Average P/E Ratio14.3
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group80.0
P/E as % of Sector Segment93.0
Current 12 Month Normalized P/E Ratio - LTM18.5
PER SHARE FIGURES
LT Debt pS70.35
Current Liabilities pS43.33
Tangible Book Value pS - LTM-43.86
Book Value pS - LTM45.94
Capital Invested pS101.34
Cash pS - LTM0.00
Cash Flow pS - LTM7.59
Free Cash Flow pS - LTM5.55
Earnings pS (EPS)-0.57
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin3.51
Free Cash Flow Margin 5YEAR AVG3.89
Net Profit Margin0.0
Net Profit Margin - 5YEAR AVRG.0.0
Equity Productivity3.34
Return on Equity (ROE)0.0
Return on Equity (ROE) - 5YEAR AVRG.0.1
Capital Invested Productivity1.48
Return on Capital Invested (ROCI)0.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.1
Assets Productivity1.30
Return on Assets (ROA)0.0
Return on Assets (ROA) - 5YEAR AVRG.0.0
Gross Profit Margin16.2
Gross Profit Margin - 5YEAR AVRG.0.2
EBITDA Margin - LTM3.5
EBIT Margin - LTM2.1
Pre-Tax Profit Margin0.0
Pre-Tax Profit Margin - 5YEAR AVRG.0.0
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.0.0
EFFICIENCY RATIOS
Cash Conversion Cycle
Revenue per Employee659,590
Net Income per Employee
Average Collection Period
Receivables Turnover19.4
Day's Inventory Turnover Ratio
Inventory Turnover10.3
Inventory/Sales8.5
Accounts Payble/Sales4.59
Assets/Revenue0.77
Net Working Capital Turnover157.68
Fixed Assets Turnover1.29
Total Assets Turnover1.3
Revenue per $ Cash47.94
Revenue per $ Plant17.15
Revenue per $ Common Equity3.34
Revenue per $ Capital Invested1.48
Selling, General & Adm/tive (SG&A) as % of Revenue0.0
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue0.0
R&D Expense as % of Revenue - 5YEAR AVRG.0.0

  


Your Recent History
NYSE
CVS
CVS Health..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.